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Objective: To quantify the extent to which clinicians use clinically-efficacious decision aids as intended during
implementation in practice and how fidelity to usage instructions correlates with shared decision making (SDM)
outcomes.
Methods: Participant-level meta-analysis including six practice-based randomized controlled trials of SDM in various
clinical settings encompassing a range of decisions.
Results: Of 339 encounters in the SDM intervention arm of the trials, 229 were video recorded and available for
analysis. The mean proportion of fidelity items observed in each encounter was 58.4% (SD = 23.2). The proportion
of fidelity items observed was significantly associated with patient knowledge (p = 0.01) and clinician involvement
of the patient in decision making (p <0.0001), while no association was found with patient decisional conflict or
satisfaction with the encounter.
Conclusion: Clinicians’ fidelity to usage instructions of point-of-care decision aids in randomized trials was
suboptimal during their initial implementation in practice, which may have underestimated the potential efficacy of
decision aids when used as intended.
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Shared decision making (SDM) is a process whereby pa-
tients and clinicians deliberate together to make deci-
sions that reflect the best available evidence about the
existing options synthesized with patients’ preferences,
values, goals and context [1]. While many definitions of
SDM exist, themes found most consistently in these def-
initions include incorporation of patient preferences and
values, presentation of options to the patient, partnering
with the patient, facilitating patient participation, educat-
ing the patient, and presentation of benefits and risks
[2]. A substantial body of evidence indicates that use of
decision aids improve outcomes thought to be important* Correspondence: LeBlanc.Annie@mayo.edu
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reproduction in any medium, provided the orcomponents of SDM, including patient knowledge, deci-
sional conflict (especially as it relates to being unclear
about personal values and feeling uninformed), and ac-
curacy of patient risk perception when compared to
usual care. The tools also increase the extent to which
clinicians engage patients in the decision making process
during consultations [3].
While many decision aids have been designed for pa-
tient use outside of the clinical encounter [3], our re-
search group has designed and studied decision aids for
use during the clinical consultation as tools to support
clinicians’ efforts to engage patients in SDM [4-8]. These
decision aids are designed to create conversations about
the available options and support those conversations
with evidence-based information about the relevant pros
and cons associated with each option presented, while
taking into consideration clinicians’ expertise and pa-
tients’ personal values and preferences [9,10]. Our user-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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decision aid will meet the needs of both users (i.e., clini-
cians and patients) and accommodate the pressures of
time-limited encounters. To date, our SDM trials have
demonstrated that our decision aids have been able to
create meaningful conversations, increase patient know-
ledge relevant to the choice to be made and increase the
extent to which clinicians involve patients in the deci-
sion making process while having variable impact on
choice and adherence to choice [5-7,11]. The efficacy of
our decision aids is based on the assumption that clini-
cians use them in accordance with the principles of
SDM, which we communicate through simple and brief
usage instructions.
Qualitative analysis of video recordings from our first
trial, ‘Statin Choice,’ clearly suggested, however, that
while most clinicians appear to use the decision aid as
intended, its design accommodated a range of clinician
uses, some of which no longer resembled SDM [11,12].
For instance, clinicians would use the decision aid to
justify their personal biases, as opposed to exploring the
patient’s preferences. Video recordings continued across
all of our trials, in both intervention and usual care
arms, creating a rich and unique database to evaluate
the extent and manner in which clinicians used decision
aids as intended during clinical encounters and how fi-
delity to intended use of decision aids modifies their
efficacy.
We reviewed video recordings from the SDM interven-
tion arm of trials where decision aids were used at the
point-of-care by clinicians and patients, and we extracted
measures of fidelity to decision aid usage instructions, pa-
tient decisional conflict, knowledge, involvement in the
decision making process, and satisfaction with the en-
counter. Our objective was to use these data to quantify
the extent to which clinicians follow the usage instructions
of the decision aids and understand how following these
instructions affects important SDM outcomes, such as pa-
tient knowledge, patient decisional conflict, and clinician
engagement of the patient. Our hypothesis was that fidel-
ity to decision aid usage instructions was less than perfect
and resulted in suboptimal SDM outcomes measured in
the included trials.Methods
Study design
We conducted a participant-level meta-analysis to assess
the extent to which clinicians used decision aids as
intended with their patients during clinical encounters
in practice-based, randomized, controlled trials of deci-
sion aids. The Mayo Clinic Institutional Review Board
(IRB) approved the study procedures described herein.
Moreover, for each of the trials included in this study,clinicians and patients provided written informed con-
sent for all study procedures, including video recording.
Decision aid development
The decision aids involved in our trials were designed
with extensive input from patients and clinicians to fit
the context of their intended use, the individual clinical
encounter, and the fast-paced setting of most practices
[9]. Our decision aids were designed to be brief, to the
point, and user-oriented, so that they would be easy to
use and adaptable to the clinical scenario. The purpose
of the decision aids was to serve as a guide that presents
the best available evidence, utilizes the clinician’s expert-
ise, and elicits the patient’s preferences and values with
the intent of creating a conversation in the context of
SDM. The training that accompanied these decision aids
was minimal and included brief video clips and story-
boards that demonstrate basic use of the targeted decision
aid (publicly available at http://shareddecisions.mayocli-
nic.org). We intended for this training to be minimal in
order to facilitate the easy adoption and implementation
of our decision aids both during and after the trials. On-
site study coordinators were available to do one-on-one
demonstrations on an as-needed basis during the trials.
Data source
We included all but one completed SDM trial conducted
through the Wiser Choices Program of the Knowledge
and Evaluation Research (KER) Unit at Mayo Clinic in
Rochester, MN, USA (Table 1). All included trials were
practice-based, 2-arm, randomized controlled trials en-
rolling clinicians and patients at the point of care in
Southeastern Minnesota, USA. They included a similar
SDM intervention (i.e., a brief decision aid to be used by
clinicians and patients during clinical encounters) and
assessed similar measures of SDM processes and out-
comes [7,13-15]. These trials also measured the com-
parative impact on clinical and utilization outcomes. We
excluded the ‘Statin Choice’ trial from this study as the
overall design and structure of the study were different
from the others [11].
Data extracted
We used all available video recordings of clinical encoun-
ters and extracted measures from baseline, post-encounter
and follow-up surveys from patients and clinicians, phar-
macy records, and third-observer reports. We included all
available data from the intervention arm of each trial.
Fidelity (intended use of the decision aid)
Considering the minimal training clinicians received in
the use of the decision aids and their varying knowledge
and application of SDM principles, we developed a fidel-
ity checklist for each of the decision aids to ensure that
Table 1 Wiser choices clinical trials included in the study
AMI choice Chest pain choice Decision aids for diabetes
(DAD)




NCT00888537 NCT01077037 NCT01029288 NCT00388050 NCT00578981,
NCT00949611
Decision Intensive medical treatment
to reduce 6-month mortality





presenting with chest pain
Use of statins to reduce
10-year cardiovascular risk









Setting Hospital Emergency department Primary care practices Primary care
practices
Primary care practices
aOsteoporosis I and II trials were pooled together as one trial is the continuity of the other.
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Additional file 1). The scale was developed by the devel-
opers of the decision aids to reflect the obligatory ele-
ments that should be part of the conversation generated
by using the decision aid. Given that each tool is unique,
the fidelity scale differs for each decision aid. The fidelity
checklist for each decision aid comprised a different num-
ber of items (all on a present/absent scale); thus total
scores are reported as a percentage of items (i.e., behav-
iors) present. Some items on the checklist are overlapping,
as they must occur in a stepwise fashion (e.g., Did the clin-
ician describe the risk as a natural frequency? Did the clin-
ician describe the time horizon for the risk? Did the
clinician describe the risk graphically? Did the clinician
describe the risk reduction as a natural frequency? Did the
clinician describe the risk reduction graphically?). For the
present study, each of these questions was scored inde-
pendently. Additional items captured data for descriptive
purposes and were not included in calculation of the fidel-
ity score. Additional file 1 details which items were in-
cluded in calculating the fidelity score. The fidelity score is
calculated as a percentage of items performed by the clin-
ician. We considered, based on clinical opinion, a fidelity
threshold of 66% (2/3 of items addressed) as a successful
(i.e., ‘as intended’) use of the decision aids. A perfect fidel-
ity score (i.e., 100%) would involve the clinician incorpor-
ating all of the components of the decision aid training.
While we hypothesize that higher fidelity scores are opti-
mal, we recognize that variability and imperfect scores
may result as clinicians tailor the decision aid to time-
limited encounters or to patients with whom they have
already previously discussed components included on the
decision aid. Taking into account this variability, we chose
a 66% fidelity score as the threshold for ‘acceptable’ use,
recognizing that this threshold is somewhat arbitrary. Ex-
amples of unskilled uses that could result in low fidelity
score include using the decision aid to convince a patient
of the clinician’s personal bias without walking the patient
through the decision aid, and omission of several key
components of the decision aid deemed essential for pa-
tient understanding of their clinical context (e.g., sharingbaseline risk as a percentage without explaining the per-
centage as a natural frequency, without explaining it visu-
ally, or without explaining the time course over which the
risk applies).
The Decision Aids to Enhance Shared Decision Making
for Diabetes (‘DAD’) trial video recordings were reviewed
in duplicate with a percentage of overlap (20%) to ensure
adequate reproducibility (concordance = 95%). The re-
mainder of trials were reviewed by a third reviewer, with
this reviewer’s reproducibility only for the ‘Chest Pain
Choice’ trial verified by comparison with an additional re-
viewer and adequate reproducibility (concordance = 92%).
Scores from only one reviewer per encounter were used to
calculate the fidelity score.
While some video recordings included the entire clin-
ical encounter, others included most but not all of the
clinical encounter (e.g., the entire consultation with
video recording stopped at the point of the physical
examination, or the beginning of the consultation
through the use of the decision aid), and some included
only the component of the clinical encounter in which
the decision aid was used. Because the entire clinical
consultation was not consistently recorded and because
the main outcome of interest was the manner in which
the clinician did or did not implement the decision aid
as instructed, only the portion of the clinical encounter
in which the decision aid was used was analyzed with
the fidelity scale.
Outcome measures
Patients’ levels of decisional conflict were assessed im-
mediately after consultations using the Decisional Con-
flict Scale (DCS) [16]. Specifically, the scale measures
personal perception of uncertainty and explores the fac-
tors contributing to that uncertainty. The scale includes
5 subscales and 16 items on a 0 to 4 Likert scale, where
scores can be reported globally or for each subscale indi-
vidually. We reported the scores for each subscale, trans-
posing them on a 0 to 100 range, with higher scores
indicating greater comfort with decision making. The
number of subscales assessed varied across trials; we
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fectiveness) in the ‘AMI Choice’ trial, three of the five
(Information, Effectiveness and Support) in the ‘DAD’
trial, and all five subscales in the remaining trials.
Patients answered true/false knowledge questions per-
taining to information considered essential in the decision-
making process for the clinical problem at hand, mainly
around cognizance of the problem, its alternatives, and as-
sociated main benefits and risks. The total knowledge
scores were expressed as a percent of the maximum pos-
sible score. When pertinent, we also asked patients to indi-
cate their individual estimated risk of adverse outcomes
(e.g., 10-year coronary risk), which we then compared with
the actual calculated risk provided in the decision aid.
Satisfaction with the encounter was measured using pa-
tients’ willingness to recommend the way they made
the decision (i.e., use of the decision aid) to others on a
7-point Likert scale, converted into two categories: recom-
mend (1 to 2) or not (5 to 7). Chart reviews provided evi-
dence about the action patients took (i.e., actual decision),
which we compared to their declared decision on post-
visit questionnaires (i.e., intended decision).
The OPTION scale, a third-observer scale, was used
to evaluate clinicians’ efforts to involve patients in SDM
[17]. The scale has 12 items scored on a 0 to 4 scale,
which are then summed to form the total score (max-
imum = 48). For ease of interpretation, we transposed
this score on a 0 to 100 range, with higher scores indi-
cating greater involvement in decision making.Socio demographic data
For each included trial, we extracted patients’ gender,
age, education, income, marital status, and insurance
plan, in addition to clinicians’ gender and type (i.e., at-
tending physician, resident physician, nurse).Statistical analyses
We presented demographics and clinical characteristics as
counts and percentages for categorical values and as
means and standard deviations for continuous values. We
conducted a sensitivity analysis using the Wilcoxon rank
sum test for continuous and Fisher’s exact for categorical
outcomes to test for differences in patient outcomes when
the clinical encounter was recorded compared to when it
was not. We are presenting each trial’s results individually
and overall to report the results of the video-recorded pa-
tients from the decision aid arm of the trials that have not
been presented elsewhere. For individual trial results, we
calculated correlations among continuous outcomes and
fidelity using the Spearman’s rank coefficient, while logistic
regression was used for binary outcomes. We conducted
meta-analysis of the included trials using a generalized lin-
ear mixed model that was stratified by trial for continuousoutcomes. We modeled adherence to decision and the fi-
delity threshold by logistic regression, stratified by trial.
We conducted all analyses using SAS 9.2 (Cary, NC)
and considered two-sided p-values <0.05 as significant.
We recorded and managed study data using the Re-
search Electronic Data Capture (REDCap) system [18].
Results
Table 2 shows characteristics of the included trials, of
the recording material available, and of the patient and
clinician participants. We were able to collect 206 video
and 23 audio recordings out of a possible 339 encoun-
ters (68%) from the SDM arms of the trials.
Fidelity (intended use of the decision aid)
Across all trials, there were six encounters in which cli-
nicians did not use the decision aid with their patients.
High level of concordance was found between fidelity
scores from the third reviewer and original reviewer
pairs (concordance between 76% and 92%) for the ‘AMI
Choice’, ‘Chest Pain Choice’, ‘Diabetes Medication Choice’,
and ‘Osteoporosis Choice’ I/II trials [19]. Considering
the high level of concordance, in addition to the fact that
he trained and supervised the reviewers for the ‘DAD’
trial, the third reviewer did not assess the video record-
ings of the ‘DAD’ trial. All results used in this study, ex-
cept for those of the ‘DAD’ trial, are from the third
reviewer (KDW).
Across all recordings, we observed 58% (95% CI 56,
62) of the fidelity items in video recordings of encoun-
ters. The range of fidelity scores was 0% to 100%. Al-
most half (47%) of the encounters addressed at least 66%
of the fidelity items. Trial-specific fidelity was on average
lower (56%) and varied across trials (39-66%). Regarding
the key expected behaviors, the degree of information
sharing and facilitation of the decision making process
was similar across trials, while elicitation of values and
preferences was highly variable between trials (Table 3).
For instance, clinicians elicited patients’ preferences and
values in 89% of the encounters within the ‘Diabetes
Medication Choice’ trial compared to none within the
‘AMI Choice’ trial (Table 3). Clinicians made recommen-
dations in 46% of the encounters, and 75% of these rec-
ommendations were unsolicited.
Association of fidelity with trial outcomes
We found significant associations between fidelity scores
and patient knowledge (p = 0.01) and patient involve-
ment in the decision making process (OPTION score)
(p <0.0001) (Table 4). We found no significant associa-
tions with the decisional conflict score or any of its sub-
scales, patient knowledge of risk, patient satisfaction
with the decision-making process, or concordance be-
tween the decision made and patient action (Table 4).












Patients enrolled to the SDM intervention arm, n 53 101 53 48 84 339
Video recordings available, n (%)b 31 (58) 98 (97) 23 (43) 28 (58) 49 (58) 229 (68)
Patients
N (% of female) 7 (23) 56 (57) 4 (17) 14 (50) 49 (100) 131 (57)
Age, mean (SD) 65 (7) 54 (12) 60 (11) 63(11) 67 (9) 60 (12)
K-12 education, n (%)c 12 (41) 27 (28) 9 (39) 10 (36) 16 (34) 74 (33)
Income <40 k/year, n (%)d 14 (47) 25 (28) 6 (26) 13 (50) 16 (38) 74 (35)
Married, n (%)e 20 (65) 45 (80) 18 (78) 12 (86) 28 (72) 123 (75)
Commercial insurance, n (%)f 16 (52) 75 (77) 8 (89) 12 (67) 17 (35) 128 (62)
Clinicians
N (% female) 3 (100) 51 (25) 16 (31) 16 (44) 36 (47) 122 (37)
Encounters per clinician, mean, median (range) 10.3, 10 (5,16) 1.9, 2 (1, 6) 1.9, 1 (1, 8) 2.6, 2 (1, 8) 1.7, 1 (1,8) 2.2, 1 (1, 16)
Typeg
Staff physician, n (%) ~ 20 (41) 12 (75) 13 (81) 25 (69) 70 (58)
Physician in training, n (%) ~ 26 (53) 2 (12.5) 0 (0) 6 (17) 34 (28)
Nurse or nurse practitioner, n (%) 3 (100) 3 (6) 2 (12.5) 3 (19) 5 (14) 16 (14)
aOsteoporosis I and II trials were pooled together as one trial is the continuity of the other; bSome recordings were not available due to technical issues
(i.e., missing sound, not readable); cValues missing for education (AMI = 2, Chest Pain Choice = 3, Osteoporosis choice I/II = 2); dValue missing for income (AMI = 1,
Chest Pain Choice = 10, Diabetes choice = 2, Osteoporosis choice I/II = 7); eValues missing for marital status (Chest Pain Choice = 42, Diabetes = 14, Osteoporosis
choice I/II = 10); fValues missing for insurance (DAD = 14, Diabetes choice = 10); gValues missing for clinician type (Chest Pain Choice = 2).
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ters with ≥66% of fidelity items addressed did not differ
in respect to outcomes. Patients’ concordance between
the action that was taken and the decision that was
made within the encounter was not significantly changed
by a higher degree of fidelity to the items being exam-
ined (Table 5).
We conducted a sensitivity analysis using a generalized
linear model for continuous and a logistic regression
model for categorical outcomes to test for differences
in patient outcomes when the clinical encounter was
recorded compared to when it was not, adjusting byTable 3 Fidelity scores




Fidelity scorea 61.0 (57.5, 64.5) 52.4 (47.1, 57.6) 62.8 (5
Information componenta 65.7 (57.3, 74.1) 52.4 (47.1, 57.6) 39.1 (2
Decision making
process componentsa
61.3 (56.7, 65.9) 63.3 (58.9, 67.6) 68.1 (5
Eliciting values/preferencesb 0 (0) 18 (18) 12
Fidelity groupingb,c 10 (32) 47 (48) 12
aPercentage of fidelity items addressed in the encounter; Mean (95% CI), unadjuste
bCount of encounters with behavior/meeting criteria (%).
c66% or more of fidelity items exhibited within the encounter.treatment arm. Differences were found among outcomes
for knowledge of risk (AMI Choice, p = 0.003), DCS cer-
tainty (Chest Pain Choice, p = 0.007), patient knowledge
(Osteoporosis Choice, p = 0.005) and satisfaction (Diabetes
Medication Choice, p = 0.01; Additional file 2).
Fidelity with repeated use of decision aids
We assessed whether fidelity scores increased with re-
peated use of decision aids. A total of 47 clinicians used
decision aids more than once, 25 used them more than
twice, and 15 used them more than 3 times, and we







1.1, 74.6) 64.6 (56.3, 72.9) 63.8 (58.2, 69.3) 58.5 (55.5, 61.5)
3.8, 54.5) 54.6 (44.1, 65.0) 63.8 (58.2, 69.3) 55.6 (52.1, 59.0)
8.4, 77.9) 62.1 (53.4, 70.9) 61.2 (54.6, 67.8) 62.9 (60.2, 65.7)
(52) 25 (89) 7 (14) 62 (27)
(52) 13 (46) 27 (55) 109 (47)
d scores.










Patient involvement (OPTION score) 0.563 0.006, R = 0.276 0.115 0.002, R = 0.556 0.641 <0.0001, R2 = 0.542
DCS overall 0.236 0.430 0.121 0.966 0.679 0.845, R2 = 0.023
DCS informed 0.146 0.216 0.174 0.593 0.646 0.589, R2 = 0.034
DCS effective 0.608 0.864 0.194 0.893 0.236 0.667, R2 = 0.031
DCS support ~ 0.399 0.457 0.674 0.576 0.261, R2 = 0.047
DCS values ~ 0.683 ~ 0.861 0.927 0.821, R2 = 0.013
DCS certainty ~ 0.946 ~ 0.968 0.470 0.690, R2 = 0.018
Knowledge ~ 0.065 0.194 0.053, R = 0.369 0.001, R = 0.455 0.011, R2 = 0.095
Knowledge of risk estimatesb 0.341 0.639 ~ ~ 0.857 0.861
Satisfaction (willingness to
recommend to others)b
0.481 0.269 0.470 0.649 0.952 0.251
Abbreviations: DCS Decisional Conflict Scale; OPTION Observing Patient Involvement.
aP-value of Spearman’s rank correlation with R for significant values.
bP-value for logistic model results; overall model stratified by study.
cGeneralized linear mixed model adjusted by fixed effect of fidelity and random effect of study.
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threshold of at least 66% of fidelity items addressed in
the first encounter appeared to suggest a trend toward
better results in the subsequent encounters for those
with four or more encounters, but due to limited num-
ber of clinicians this could not be tested. Table 6 shows
patient and clinician characteristics of encounters in
which clinicians used decision aids at least thrice in the
included trials.
Discussion
We found, after the initial implementation effort, that cli-
nicians used decision aids as intended only partially and
inconsistently, that key elements of decision aid use were
missing from most encounters, and that fidelity scores in-
completely correlated with important outcomes of deci-
sion aid use. When decision aids were used, clinicians
made recommendations in nearly one half of clinical en-
counters; moreover, three-fourths of these recommenda-
tions were unsolicited.
Interestingly, different components of the fidelity score
were implemented variably between studies. The obser-
vation that clinicians did not elicit values/preferences
during the ‘AMI Choice’ study was likely a consequence
of the study design. ‘AMI Choice’ was the only included
study where the clinician presenting the decision aid was
not the patient’s clinician, and their only contact withTable 5 Adherence to decision values and association with fid
AMI choice Chest pain choice DAD
Adherent to decision, n (%) 23 (88) 66 (70) 11 (85)
Mean difference of fidelity for
Adherent vs. not, % (95% CI)
−2 (−15, 11) 2 (−9, 14) −6 (−46,
aOdds ratio (95% CI), logistic regression stratified by study.the patient was for the exclusive purpose of delivering
the decision aid intervention. In this sense, the decision
aid was presented as more of an educational encounter.
Limitations and strengths
While fidelity was correlated with OPTION score, it is
possible that this observed association is spurious. While
the intent of the fidelity scale was objective measure-
ment of the mechanical steps of decision aid use by the
clinician which are thought to facilitate SDM, the OP-
TION scale acted as a direct measure of the SDM
process. Nonetheless, some overlap in scoring items is
to be expected between different measures relating to
SDM since the intended outcome being measured is
similar. Thus, the finding of correlation between fidelity
and patient involvement in the decision making process
(i.e., OPTION scores) may in part be explained by the
overlap in items between these measures: both evaluate
the extent to which clinicians elaborated on the problem
that requires a decision, operated within the context of
uncertainty about the best course of action, presented
more than one option to the patient, and explained the
pros and cons associated with the options. However, the
fidelity checklist did not include items similar to those
on the OPTION scale addressing the extent to which
clinicians explored patient expectations and concerns,
verified patient understanding, provided opportunities toelity
Diabetes medication choice Osteoporosis choice Alla
20 (83) 19 (63) 139 (74)
33) 10 (−13, 33) −13 (−29, 3) 0.85 (0.2, 3.6)
Table 6 Compliant (>66%) in fidelity items in the first three consecutive encounters for clinicians who participated in
included trials at least three timesa








n (%) n (%) n (%)
Clinician characteristics
Type: Staff physician 5 (63) 3 (60) 7 (58)
Physician in training 3 (38) 1 (20) 3 (25)
Nurse or nurse practitioner 0 1 (20) 2 (17)
Female 3 (38) 1 (20) 4 (33)
Patient characteristics from encounters
Sex: Majority male 4 (50) 2 (40) 5 (42)
Majority female 4 (50) 3 (60) 7 (58)
Age, y: Majority <65 7 (87.5) 2 (40) 11 (92)
Majority ≥65 1 (12.5) 3 (60) 1 (8)
Education: majority collegeb 5 (25) 3 (60) 10 (83)
Majority HS or less 3 (25) 2 (40) 2 (17)
Abbreviations: HS High School.
aClinicians with at least 3 encounters (n = 25) were included, the first three encounters were evaluated for compliance to fidelity of 66% or more in
each encounter.
bCollege includes post-grad, four-year degree, two-year degree and vocational school.
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volvement, signaled the need for a decision making stage,
or indicated the need to review the decision. Instead, the
fidelity scale placed an emphasis on actions clinicians took
to increase patient understanding of their options (e.g.,
‘Did the clinician explain risk reduction graphically?’) and
were often decision aid specific. Indeed, the significant re-
lationship between fidelity and patient knowledge that we
observed may reflect the emphasis that the fidelity check-
list places on knowledge transfer behaviors as opposed to
other behaviors thought to be associated with SDM. The
observation that the fidelity checklist emphasized know-
ledge transfer behaviors over elicitation of patient prefer-
ences/values and partnership with patients yet still was
associated with increased OPTION scores suggests that
knowledge transfer serves to engage patients in shared de-
cision making.
The recording of what takes place in the clinical consult-
ation in the context of randomized trials of decision aids is
an important component of understanding how these tools
work. While logistically complicated for study personnel
and participants, we managed to video record a fairly large
proportion of encounters, but not all. Whether this intro-
duces bias into our results is unclear; in our judgment, cli-
nicians and patients that consent to video may consider
themselves most compliant with study procedures and
should be exhibiting the highest adherence to instructions
of decision aid use. Thus, our findings may represent an
overestimate of actual clinician fidelity.Moreover, because the entire clinical consultation was
not consistently recorded and our main outcome of
interest was fidelity to the implementation of the deci-
sion aid, we analyzed only the portion of the clinical en-
counter where the decision aid was utilized in those
recordings that were available. While we presume that
this portion of the clinical consultation is what results in
the measured outcomes (e.g., patient decisional conflict,
patient knowledge), it is possible that other components
of the clinical encounter that were not recorded or ana-
lyzed could have contributed to the outcomes of interest
and that fidelity does not necessarily represent a direct
correlation with SDM in all clinical encounters.
Beyond the ability to peer into the ‘black box’ of the
clinical encounter, our study offers the strength of com-
pleting reproducible assessments while considering dif-
ferent decisions (e.g., medication options, disposition
from the emergency department, risk reduction), clinical
contexts (e.g., routine chronic care, emergency care, hos-
pital discharge), patient types (return versus new) and
clinician types (e.g., inpatient nurses, primary care physi-
cians, emergency care physicians, physicians in training).
Because we conducted all of these studies with tools we
developed, there is considerable uncertainty about the
applicability of our findings to other decision aids and
contexts. Nonetheless, it serves as a proof-of-concept
that can be applied to study the fidelity with which clini-
cians adhere to SDM interventions in a variety of clinical
contexts and used by those developing decision aids to
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beit imperfect, this is, to our knowledge, the first assess-
ment of the fidelity of use of point-of-care tools to
support SDM.
Conclusion
Clinicians’ fidelity to intended use of point-of-care deci-
sion aids in randomized trials was suboptimal and sug-
gests that those trials may have underestimated the
efficacy of decision aids when used as intended. Alterna-
tively, these findings challenge our assumptions of what
are key components of effective decision aids and the
role of decision aids in creating meaningful conversa-
tions that facilitate SDM.
Practice implications
The trials from which we drew the encounter videos
used in this study all concluded that the tools were ef-
fective in promoting SDM, improving patient know-
ledge, and increasing patient involvement, at the current
level of fidelity. Therefore, while fidelity to the intended
use of decision aids may be important, it may not be
completely necessary to achieve acceptable levels of
SDM. Alternatively, other factors may be more import-
ant for facilitating high levels of SDM. However, we did
observe that higher clinician fidelity was associated with
important SDM outcomes, suggesting that more faithful
implementation of the decision aids may lead to greater
patient knowledge and increased involvement of the pa-
tient by the clinician regardless of the role other factors
play. Alternative implementation strategies, including in-
novative approaches to training in SDM and further re-
finement of the decision aids may provide a means to
increase SDM in this context.
Long lists of barriers and facilitators for SDM have
been published [20,21]. Key barriers include patient
characteristics, the clinical situation, patient preferences,
and time pressures, whereas key facilitators include clin-
ician motivation, patient characteristics, and the practi-
cality of SDM in the clinical context [21]. Our trials
have shown that many of these barriers fail to operate in
the context of our decision aids, including concerns for
time, lack of pertinence to the patients seen, and willing-
ness to use (with 70% to 95% of patients and clinicians
declaring interest in using the tools the next time they
face a similar decision across our studies). Detailed ana-
lyses within the ‘black box’ of the clinical encounter,
however, reveal how tenuous the unskilled implementa-
tion of decision aids can be and how much potential effi-
cacy may not have been realized in our trials. While the
fidelity checklist highlights several behaviors thought to
facilitate SDM, including transfer of knowledge and fa-
cilitation of patient understanding of difficult concepts,
it is relatively mute on other facilitators, such asclinician motivation, clinician interpersonal skills and
patient characteristics. While these latter facilitators are
challenging to quantify given their nature, they undoubt-
edly play a key role in facilitating SDM. Our analysis
gave some insight into the role clinician bias can play as
a barrier to SDM. Although not included in the calcula-
tion of the overall fidelity score, we observed that clini-
cians made recommendations to patients about the
course of action to take in 46% of encounters, and 75%
of these recommendations were not solicited by the pa-
tient. Although it is possible that some of these recom-
mendations reflected a skillful synthesis of the patient’s
stated values and preferences with the best available evi-
dence, the video reviewers qualitatively noted that these
recommendations usually appeared to reflect personal
biases the clinician had implied earlier in the clinical
consultation. Although clinician recommendations in
the context of these trials may not put patients at risk
for physical harm, given that there was clinical equipoise
with respect to all of the included decisions, patients are
harmed when they are not permitted to make decisions
in keeping with their personal values and preferences.
Therefore, while training interventions like those used in
our decision aid trials may play a role in facilitating
SDM by ensuring that certain steps are followed in the
use of decision aids, SDM may yet reach its full potential
through addressing more basic issues of interpersonal
skills and motivation of the professional and the profes-
sional culture of SDM.
Although suboptimal, when considered in the context
of the minimal training used with these decision aids,
the observation that a mean fidelity score of 58% was
observed in our trials should be considered a success.
While higher fidelity scores appear to be associated with
important outcomes and thus are optimal, we recognize
that 100% fidelity may not be feasible for every clinical
encounter. For instance, a clinician may be operating in
a time-limited encounter and choose to focus on only
the most pertinent aspects of the decision aid for the in-
dividual patient. Although imperfect implementation of
our decision aids is not ideal, it is preferred to the alter-
native of the clinician making a paternalistic decision on
behalf of the patient without consideration of their per-
sonal context. Alternatively, because a patient and clin-
ician may have already discussed aspects of the patient’s
care covered on the decision aid in previous discussions,
a clinician may be able to forego certain aspects of the
usage instructions included on the fidelity checklist. Our
results did show a wide range of fidelity scores, suggest-
ing that there are ‘bright spots’ where fidelity is perfect,
and ‘dark spots’ where fidelity is zero. Further explor-
ation of ‘bright spots’ and ‘dark spots’ may shed light on
barriers and facilitators of optimal decision aid imple-
mentation. This analysis may reveal which aspects of
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are perhaps less important. Ultimately, while it is clear
that the behaviors on the fidelity checklist are important
for facilitating knowledge transfer and engagement of
the patient, the role of other clinician behaviors in facili-
tating SDM remains unclear.
While there remain many definitions of shared deci-
sion making, all of which place variable emphasis on dif-
ferent clinician behaviors [2], we operationalize SDM in
its most basic form as a conversation between the clin-
ician and patient where the clinician brings knowledge
based on the best available evidence and the patient
brings his or her personal preferences, and the two are
merged. We have shown that specific clinician behaviors
included on the fidelity scale facilitate the one-way
transfer of knowledge from clinician to patient and also
serve to engage the patient in the clinical encounter, and
therefore, these behaviors should be highlighted when
decision aid use is demonstrated. However, our study
leaves questions about other facilitators of SDM when
decision aids are used, such as personal attributes of the
clinician, explicit values clarification exercises, and the
culture of the medical practice. It is also unclear what
role patients might play in facilitating SDM, as our study
only analyzed clinician behaviors. We have also only an-
alyzed shared decision making in the context of decision
aids, fully realizing that decision aids are not a pre-
requisite for SDM.
Our findings may justify an emphasis on the need for
a patient-centered culture in which to frame SDM.
While it is plausible that the unsolicited recommenda-
tions clinicians made in the context of these trials were
offered according to the clinicians’ understanding of pa-
tients’ personal needs, values and preferences in accord-
ance with SDM, our reviewers judged that the vast
majority of unsolicited recommendations seemed to in-
stead reflect the clinicians’ personal agendas. This find-
ing, if replicated, would suggest that clinicians are still
reluctant to let patients participate in decision making
when the views of the patient might differ from those of
the clinician [12]. Together, poor clinician fidelity to the
presentation of options with their pros and cons and
failure to frame the discussion within the context of un-
certainty about a clear ‘best’ course of action represent
poor clinician uptake and implementation of core tenets
of SDM.
An alternative implication of our findings is that the
elements of decision aid use we thought were key are in
fact not technically necessary to promote SDM, thus
explaining the lack of correlation of fidelity with other
trial outcomes. As explained above, the fidelity checklist
only takes into account certain quantifiable behaviors,
but other factors including interpersonal skills, motiv-
ation of the professional, and the professional culturecertainly play a role. This questions the validity of the
checklist as a standalone tool and more importantly of
our assumptions about how decision aids work. Readers
can directly judge the face validity of our fidelity check-
list (see Additional file 1). Also, it may be important to
debate whether all checklist items should carry the same
weight or whether some items should be considered es-
sential or given greater weight.
Given our findings, we invite the community conduct-
ing research on SDM to not leave the effects of their in-
terventions on the clinical encounter within a ‘black
box.’ It is evident that a simple checklist approach may
contribute to the analysis of SDM intervention imple-
mentation, but more sophisticated video coding may
yield greater insights. For instance, the fidelity checklist
noted the presence or absence of behaviors, but did not
note their duration or the sequence in which they mani-
fested. Other video coding techniques may support these
analyses and could be applied to the same recordings an-
alyzed here and others as they accrue as part of the rou-
tine conduct of our work [22]. If other groups were to
also video record encounters – both intervention and
control – we could conduct more comparative work and
pool results, increasing precision and applicability.
Additional files
Additional file 1: Fidelity checklist items.
Additional file 2: Comparison of encounters that were video
recorded versus not.
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